Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review.
about
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?What happened to posteroventral pallidotomy for Parkinson's disease and dystonia?Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Imaging of the subthalamic nucleus for deep brain stimulation: a systematic review.Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease.Perioperative stroke: evaluation, management, and possible preventive measures.Neuropsychology for movement disorders neurosurgery.Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi.Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations.Are complications less common in deep brain stimulation than in ablative procedures for movement disorders?Deep Brain Stimulation Targets, Technology, and Trials: Two Decades of Progress.Surgical insights into Parkinson's disease.Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis.Late (Complicated) Parkinson's Disease
P2860
Q27021464-4113C4EE-4BF7-486D-964E-919D9250FE0FQ30371432-7100D275-D988-49C8-9542-E9CB6089C4B2Q30377838-0FA2641D-D56A-4D82-8F2F-A9268D827562Q33260251-17624A0B-BB45-4D0C-B146-4E49B1D3974EQ34093962-2A06BBFE-DCBD-49DD-8CA4-7B991B28249CQ34341299-55552D7A-1D06-4ED7-9E76-18A31103E618Q35036027-B7B8CBC4-4E9D-4718-8084-7FA8644F7909Q35105765-2F23047A-87D3-425B-B3C6-40BB27768B9EQ36226290-6FC36128-90F9-40B4-A54A-59FAF12182F8Q38070888-10E111C6-5058-454C-B3B0-BDD3FAA1D37AQ41549333-E43F8DF5-5522-4EC1-BA95-B51EADDF7BE3Q48439612-FCD3447F-37F7-47E9-B864-DE83B0A05F30Q48491053-1812EA42-B9DC-47C0-8482-CFCD2597FA2EQ48630229-673F47B0-B60D-4998-BDD5-5475EC2286FAQ51211712-F619613B-DF96-406C-AA10-8EA80565AEC9Q51901620-CFBFC7D0-C338-4BA0-AFB1-BF074B97E288Q58870320-E0DF54EF-2D4C-4AE2-8538-D53351CA2C17
P2860
Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Morbidity and mortality follow ...... disease: a systematic review.
@ast
Morbidity and mortality follow ...... disease: a systematic review.
@en
Morbidity and mortality follow ...... disease: a systematic review.
@nl
type
label
Morbidity and mortality follow ...... disease: a systematic review.
@ast
Morbidity and mortality follow ...... disease: a systematic review.
@en
Morbidity and mortality follow ...... disease: a systematic review.
@nl
prefLabel
Morbidity and mortality follow ...... disease: a systematic review.
@ast
Morbidity and mortality follow ...... disease: a systematic review.
@en
Morbidity and mortality follow ...... disease: a systematic review.
@nl
P2093
P356
P1433
P1476
Morbidity and mortality follow ...... disease: a systematic review.
@en
P2093
Esselink RA
Schuurman PR
Speelman JD
de Haan RJ
P304
P356
10.1212/WNL.58.7.1008
P407
P577
2002-04-01T00:00:00Z